Screening Splice-Switching Antisense Oligonucleotides in Pancreas-Cancer Organoids

Scientists reported an efficient antisense-oligonucleotide lipofection method to systematically evaluate and screen individual splicing events as therapeutic targets in pancreatic ductal adenocarcinoma organoids.